JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez, X.
Right arrow Articles by Navarro, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez, X.
Right arrow Articles by Navarro, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 44, Issue of October 31, 1997 pp. 27529-27531

COMMUNICATION:
Activation of HIV-1 Coreceptor (CXCR4) Mediates Myelosuppression*

(Received for publication, July 31, 1997, and in revised form, September 10, 1997)

Ximena Sanchez , Beth Cousins-Hodges , Tonia Aguilar , Peter Gosselink , Zhijian Lu Dagger and Javier Navarro §

From the Department of Physiology & Biophysics and Sealy Center for Molecular Science, University of Texas Medical Branch, Galveston, Texas 77555 and Dagger  Genetics Institute, Cambridge, Massachusetts 02140

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES


ABSTRACT

Chemokines are cytokines that activate and induce the migration of leukocytes. Stroma-derived factor-1 (SDF-1) is a novel chemokine that blocks the entry of T-tropic HIV-1 mediated by fusin/CXCR4/LESTR (leukocyte-derived seven-transmembrane domain receptor). In this work we demonstrate that SDF-1 triggers increases in intracellular calcium and inhibits the proliferation of myeloid progenitor cell line 32D. By contrast, SDF-1 neither triggers a calcium response nor affects the proliferation of the myeloid progenitor cell line 32D-GR that is deficient in CXCR4. Responsiveness to SDF-1 was rescued by transfection of 32D-GR cells with a cDNA encoding the human CXCR4. The data indicate that SDF-1 induces myelosuppression by activation of CXCR4. The constitutive production of SDF-1 by bone marrow stromal cells argues for a major role of SDF-1 on the regulation of myelopoiesis.


INTRODUCTION

Chemokines are peptides of 70-100 amino acids secreted by many cell types in response to injury and infection. Two major subfamilies of chemokines are distinguished according to the position of the first two cysteines, the CXC or CC. Chemokines activate and induce migration of leukocytes in a cell-specific fashion (1). SDF-11 is a CXC chemokine secreted constitutively from several cell types. Two isoforms of SDF-1 have been identified, alpha  and beta , which are generated by differential splicing (2). SDF-1 was initially characterized as a pre-B-cell stimulatory factor (3). Recently, SDF-1 has been identified as a highly efficient chemotactic factor for T-cells, monocytes (4), and CD34+ human progenitor cells (5). The constitutive expression of SDF-1 by many tissues has suggested that SDF-1 plays a key role in homing T-cells and monocytes under basal conditions (4). Targeted disruption of the SDF-1 gene in mice was shown to be lethal with severe abnormalities in B-cell lymphopoiesis, bone marrow myelopoiesis, and development of the cardiac ventricular septum (6). The signaling of SDF-1 is mediated by CXCR4/fusin/LESTR (leukocyte-derived seven-transmembrane domain receptor), a G protein-coupled receptor expressed preferentially in leukocytes (4, 7-9). Recent studies have demonstrated that CXCR4 is the coreceptor for the entry of T-tropic HIV-1 (10) and HIV-2 (11) into CD4+ and CD4- cells, respectively. Of importance is the observation that SDF-1 blocked the entry of T-tropic HIV-1 strains (7, 8). Since SDF-1 is constitutively expressed by bone marrow cells we investigated whether SDF-1 also regulates myelopoiesis. Our data indicate that SDF-1 induces myelosuppression of bone marrow-derived cell line 32D by activation of CXCR4.


EXPERIMENTAL PROCEDURES

Cell Cultures and Transfections

The murine IL-3-dependent 32D and 32D-GR cell lines were kindly provided by Dr. J. Greenberger, University of Pittsburgh Medical School, Pittsburgh, PA. These cell lines were maintained in RPMI 1640 plus 15% heat-inactivated fetal bovine serum and 15% conditioned medium from the murine myelomonocytic cell line WEHI-3B as a source of crude IL-3 (12). Cells were cultured at 37 °C in a 5% CO2 atmosphere and maintained at a cell density of 0.5 × 106 cells/ml. 32D-GR cells (107 cells/ml) were transfected by electroporation with the human CXCR4 cDNA subcloned into the unique EcoRI site of the expression vector pMEXneo (13). Transfected cells were selected by growing the cells in the presence of 500 µg/ml G418. Colonies were scored on days 7 and 14 of culture.

Expression and Purification of SDF-1

To prepare the murine SDF-1 (mSDF-1) proteins, the cDNA fragment encoding mature mSDF-1alpha or mSDF-1beta was subcloned into the Escherichia coli expression vector pAL781 (14) behind the translation initiation codon ATG. The protein expression was carried out in the E. coli strain GI934 as described (15). Inclusion bodies were harvested, washed sequentially with buffers containing 1 M NaCl and 0.5% Triton X-100, solubilized in 6 M guanidine HCl, and then dialyzed against a pH 6.5 buffer containing 15 mM sodium acetate, 15 mM sodium phosphate, 1 mM phenylmethylsulfonyl fluoride, and 1 mM p-aminobenzamidine. The refolded mSDF proteins were then further purified from the clarified dialysates by ion-exchange chromatography.

Agar Colony Assays

Cultures of 32D or 32D-GR cells were carried out as described by Metcalf (16). In brief, 300 cells were seeded in 35-mm Petri dishes containing 1 ml of Iscove's modified Dulbecco's medium supplemented with 10% heat-inactivated fetal bovine serum, 0.3% agar, and IL-3 or 10% of conditioned medium from the cell line WEHI-3B. SDF-1 resuspended in phosphate-buffered saline or an equal volume of phosphate-buffered saline was added to the empty culture dish prior to the addition of the cell suspension in agar medium. After 7 days of incubation clusters of 50 or more cells were scored as colonies.

Intracellular Calcium Measurements

Exponentially growing 32D or 32D-GR cells were harvested by centrifugation and resuspended in a solution containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM NaHPO4, 5 mM glucose, 20 mM Hepes pH 7.4, 1 mg/ml bovine serum albumin, and 1 mM Probenecid. Cells (107/ml) were loaded with 5 µM of the calcium-sensitive dye Indo-1AM for 1 h at room temperature as described previously (17). Intracellular calcium levels were monitored at 37 °C with a spectrofluorimeter (Perkin-Elmer 650-10S) using an excitation wavelength of 330 nm and an emission wavelength of 405 nm.

Northern Blot Analysis

Total RNA (10 µg) was fractionated on denaturating formaldehyde gels and transferred onto nylon membranes. RNA was hybridized with 32P-labeled cDNA encoding human CXCR4. Blots were washed twice in 0.25 × SSC, 0.1% SDS at 55 °C for 30 min and once in 0.1 × SSC, 0.1% SDS at 65 °C for 15 min. Blots were exposed to x-ray film at -80 °C for 24 h.


RESULTS AND DISCUSSION

Since SDF-1 is constitutively expressed by bone marrow-derived stromal cells (2) we investigated whether SDF-1 plays a role in myelopoiesis. SDF-1-induced intracellular signals in myeloid precursor cells were monitored by increases in the level of intracellular Ca2+. We found that SDF-1alpha or -beta increased the intracellular Ca2+ in 32D cells (Fig. 1), a non-tumorigenic cell line that exhibits features of normal myeloid progenitor cells (16). In contrast to leukemic cell lines, the proliferation of 32D cells requires the presence of IL-3 (18). The Ca2+ response mediated by SDF-1beta was concentration-dependent, and a maximal response was achieved with 100 nM SDF-1beta (Fig. 1). Cells treated with SDF-1alpha or -beta were weakly responsive to subsequent additions of SDF-1alpha or -beta showing homologous desensitization. Other chemokines including IL-8, MIP-2, neutrophil activating peptide-2, platelet factor-4, melanocyte growth stimulatory activity, monocyte chemotactic protein-1, or ATP did not desensitize the Ca2+ response mediated by SDF-1beta . The SDF-1-induced calcium responses in 32D cells were similar to those previously observed with T-cells and monocytes (7). In addition, SDF-1beta failed to induce calcium responses in 32D cells pretreated with pertussis toxin (data not shown), demonstrating that the SDF-1beta receptor is coupled to Gi proteins. To evaluate the functional role of SDF-1 on myeloid progenitor cells we tested the effect of SDF-1beta on the proliferation of 32D cells using agar colony assays (16). Like normal hematopoietic progenitor cells, 32D cells form colonies in semisolid culture that are strictly dependent on the presence of IL-3. As shown in Fig. 2, SDF-1beta inhibited colony formation of 32D cells, suggesting that SDF-1beta is a myelosuppressor.


Fig. 1. SDF-1 induces mobilization of intracellular Ca2+. Increases of intracellular Ca2+ were recorded upon addition of 25 nM SDF-1alpha or -beta (A and B). Each experiment has been reproduced at least three times. Concentration dependence of SDF-1beta -induced mobilization of intracellular Ca2+ is shown (C and D). Concentrations of SDF-1beta added to 32D cells loaded with Indo-1 were: 2, 5, 10, 20, 40, 60, 100, and 150 nM. Results are representative of three separate experiments.

[View Larger Version of this Image (17K GIF file)]



Fig. 2. Inhibition of proliferation of progenitor cells by SDF-1. Effect of SDF-1 on colony formation of 32D cells (bullet ), 32D-GR (black-square), and 32D-GR transfected with CXCR4 cDNA (bullet ). Each point represents the average of two independent experiments. The standard deviations of the responses of 32D-GR cells transfected with CXCR4 cDNA are indicated by bars. The variability of responses of 32D and 32D-GR cells is negligible.

[View Larger Version of this Image (18K GIF file)]


To determine whether the calcium responses and suppression of proliferation of 32D cells are mediated by activation of the HIV-1 coreceptor CXCR4 we first explored the expression of CXCR4 in 32D cells by Northern blot analysis. Blots of RNA extracted from 32D cells, Jurkat T cells, and white blood cells were probed with human CXCR4 cDNA. As shown in Fig. 3, all these cells express the mRNA of CXCR4. Second, we found that 32D-GR cells (19), a cell line derived from 32D cells, neither express the mRNA of CXCR4 (Fig. 3) nor exhibit the typical SDF-1beta -dependent Ca2+ response (Fig. 4). However, similarly to 32D cells, 32D-GR cells exhibit the typical ATP-dependent Ca2+ responses (Fig. 4, A and C), form colonies in semisolid culture, and require IL-3 for proliferation. Both 32D and 32D-GR form a similar number of colonies; however, SDF-1beta failed to inhibit the proliferation of 32D-GR cells (Fig. 4). Finally, responsiveness to SDF-1 was rescued by transfection of 32D-GR with human CXCR4 cDNA. Figs. 2 and 4 show that SDF-1 triggers a calcium response and inhibits proliferation of 32D-GR cells expressing the human CXCR4. These data indicate that SDF-1beta induces myelosuppression by activation of CXCR4. Previously, several chemokines including IL-8, platelet factor-4, MIP-1alpha , and MIP-1beta have shown myelosuppressive activity in bone marrow myeloid progenitor cells; however, the heterogeneity and low frequency of precursor cells from bone marrow has precluded the identification of receptor systems that mediate the effect of these chemokines (20-22). It is unlikely that these chemokines mediate their myelosuppressive activity via CXCR4 since they do not activate CXCR4 or desensitize the calcium responses mediated by SDF-1. Probably, these chemokines bind specific receptors. Indeed, we have recently shown the endogenous expression of the murine homolog of the human IL-8 receptor B in 32D cells.2 The constitutive expression of SDF-1 by bone marrow stromal cells strongly argues for a major role of the HIV-1 coreceptor CXCR4 on myelopoiesis.


Fig. 3. Expression of CXCR4 mRNA. Northern blots were probed with a human cDNA encoding CXCR5 labeled by a random priming procedure. Lanes: 32D cells; white blood cells (WBC); Jurkat cells; 32D-GR cells.

[View Larger Version of this Image (49K GIF file)]



Fig. 4. Mobilization of intracellular calcium in CXCR4-deficient cells and cells rescued by transfection with human CXCR4 cDNA. SDF-1beta (25 nM) or ATP (500 nM) were added to: A, 32D cells; B, 32D-GR cells; and C, 32D-GR cells transfected with human CXCR4 cDNA. The experiments have been reproduced at least three times.

[View Larger Version of this Image (12K GIF file)]



FOOTNOTES

*   This work was supported by National Institutes of Health Grant R01 AI 34031.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed: Dept. of Physiology & Biophysics, Rt 0641, University of Texas Medical Branch, Galveston, TX 77555-0641. Tel.: 409-772-5480; Fax: 409-772-3381; E-mail: jnavarro{at}mspo2.utmb.med.edu.
1   The abbreviations used are: SDF-1, stroma-derived factor-1; HIV, human immunodeficiency virus; IL, interleukin; mSDF-1, murine SDF-1; MIP, macrophage inflammatory protein.
2   X. Sanchez, K. Suetomi, B. Hodges, J. Horton, and J. Navarro, unpublished results.

ACKNOWLEDGEMENT

We thank Nancy Wilkinson for helping with the agar colony assays.


REFERENCES

  1. Baggiolini, M., Dewald, B., and Moser, B. (1994) Adv. Immunol. 55, 97-179 [Medline] [Order article via Infotrieve]
  2. Tashiro, K., Tada, H., Heilker, R., Shirozu, M., Nakano, T., and Honjo, T. (1993) Science 261, 600-602 [Abstract/Free Full Text]
  3. Nagasawa, T., Kikutani, H., and Kishimoto, T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2305-2309 [Abstract/Free Full Text]
  4. Bleul, C. C., Fuhlbrigge, R. C., Casasnova, J. M., Aiuti, A., and Springer, T. A. (1996a) J. Exp. Med. 184, 1101-1109 [Abstract/Free Full Text]
  5. Aiuti, A., Webb, I. J., Bleul, C., Springer, T., and Gutierrez-Ramos, J. C. (1997) J. Exp. Med. 185, 111-120 [Abstract/Free Full Text]
  6. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., and Kishimoto, T. (1996) Nature 382, 635-638 [CrossRef][Medline] [Order article via Infotrieve]
  7. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J. M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M., and Moser, B. (1996) Nature 382, 833-835 [CrossRef][Medline] [Order article via Infotrieve]
  8. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., and Springer, T. A. (1996b) Nature 382, 829-833 [CrossRef][Medline] [Order article via Infotrieve]
  9. Loetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., and Moser, B. (1994) J. Biol. Chem. 269, 232-237 [Abstract/Free Full Text]
  10. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996) Science 272, 872-877 [Abstract]
  11. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau-Haggarty, Choe, S., Vance, P. J., Wells, T. N. C., Power, C. A., Suttewala, S. S., Doms, R. W., Landau, N. R., and Hoxie, J. A. (1996) Cell 87, 745-756 [CrossRef][Medline] [Order article via Infotrieve]
  12. Otha, M., Anklesaria, P., Fitzgerald, T. J., Kase, K., Leif, J., Delamarter, J., Farber, N., Wright, E., and Greenberger, J. (1989) Pathol. Immunopathol. Res. 8, 1-20 [Medline] [Order article via Infotrieve]
  13. Watowich, S. S., Hilton, D. J., and Lodish, H. F. (1994) Mol. Cell. Biol. 14, 3535-3549 [Abstract/Free Full Text]
  14. LaVallie, E. R., DiBlasio, E. A., Kovacic, S., Grant, K. L., Schendel, P. F., and McCoy, J. M. (1993) Biotechnology 11, 187-193 [CrossRef][Medline] [Order article via Infotrieve]
  15. Lu, Z., DiBlasio-Smith, E. A., Grant, K. L., Warne, N. W., LaVallie, E. R., Collins-Racie, L. A., Follettie, M. T., Williamson, M. J., and McCoy, J. M. (1996) J. Biol. Chem. 271, 5059-5065 [Abstract/Free Full Text]
  16. Metcalf, D. (1985) Blood 65, 357-362 [Abstract/Free Full Text]
  17. Grynkyewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem 260, 3440-3450 [Abstract/Free Full Text]
  18. Greenberger, J. S., Sakakeeny, M. A., Humphries, R. K., Eaves, C. J., and Eckner, R. J. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2931-2935 [Abstract/Free Full Text]
  19. Valtieri, M., Tweardy, D. J., Caracciolo, D., Johnson, K., Maviolio, F., Altmann, S., Santoli, D., and Rovera, G. (1987) J. Immunol. 138, 3829-3835 [Abstract]
  20. Broxmeyer, H. E., Sherry, B., Cooper, S., Lu, L., Maze, R., Beckmann, M. P., Cerami, A., and Ralph, P. (1993) J. Immunol. 150, 3448-3458 [Abstract]
  21. Broxmeyer, H. E., Cooper, S., Hague, N., Benninger, L., Sarris, A., Cornetta, K., Vadhan-Raj, S., Hendrie, P., and Mantel, C. (1995) Ann. Hematol. 71, 235-246 [Medline] [Order article via Infotrieve]
  22. Daly, T. J., LaRosa, G. J., Dolich, S., Malone, T. E., Cooper, S., and Broxmeyer, H. E. (1995) J. Biol. Chem. 270, 23282-23292 [Abstract/Free Full Text]

Volume 272, Number 44, Issue of October 31, 1997 pp. 27529-27531
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yoon, Z. Liang, X. Zhang, M. Choe, A. Zhu, H. T. Cho, D. M. Shin, M. M. Goodman, Z. Chen, and H. Shim
CXC Chemokine Receptor-4 Antagonist Blocks Both Growth of Primary Tumor and Metastasis of Head and Neck Cancer in Xenograft Mouse Models
Cancer Res., August 1, 2007; 67(15): 7518 - 7524.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Kucia, R. Reca, K. Miekus, J. Wanzeck, W. Wojakowski, A. Janowska-Wieczorek, J. Ratajczak, and M. Z. Ratajczak
Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF-1-CXCR4 Axis
Stem Cells, August 1, 2005; 23(7): 879 - 894.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. J. C. Rombouts, B. Pavic, B. Lowenberg, and R. E. Ploemacher
Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia
Blood, July 15, 2004; 104(2): 550 - 557.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K.-i. Oonakahara, W. Matsuyama, I. Higashimoto, M. Kawabata, K. Arimura, and M. Osame
Stromal-Derived Factor-1{alpha}/CXCL12-CXCR 4 Axis Is Involved in the Dissemination of NSCLC Cells into Pleural Space
Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kijima, G. Maulik, P. C. Ma, E. V. Tibaldi, R. E. Turner, B. Rollins, M. Sattler, B. E. Johnson, and R. Salgia
Regulation of Cellular Proliferation, Cytoskeletal Function, and Signal Transduction through CXCR4 and c-Kit in Small Cell Lung Cancer Cells
Cancer Res., November 1, 2002; 62(21): 6304 - 6311.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L.-P. Weng, J. L. Brown, K. M. Baker, M. C. Ostrowski, and C. Eng
PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway
Hum. Mol. Genet., July 15, 2002; 11(15): 1687 - 1696.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Alberich Jorda, S. E. Verbakel, P. J. M. Valk, Y. V. Vankan-Berkhoudt, M. Maccarrone, A. Finazzi-Agro, B. Lowenberg, and R. Delwel
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol
Blood, April 15, 2002; 99(8): 2786 - 2793.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Cashman, I. Clark-Lewis, A. Eaves, and C. Eaves
Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice
Blood, February 1, 2002; 99(3): 792 - 799.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Kijowski, M. Baj-Krzyworzeka, M. Majka, R. Reca, L. A. Marquez, M. Christofidou-Solomidou, A. Janowska-Wieczorek, and M. Z. Ratajczak
The SDF-1-CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells
Stem Cells, September 1, 2001; 19(5): 453 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. McBreen, S. Imlach, T. Shirafuji, G. R. Scott, C. Leen, J. E. Bell, and P. Simmonds
Infection of the CD45RA+ (Naive) Subset of Peripheral CD8+ Lymphocytes by Human Immunodeficiency Virus Type 1 In Vivo
J. Virol., May 1, 2001; 75(9): 4091 - 4102.
[Abstract] [Full Text]


Home page
BloodHome page
R. Guerriero, G. Mattia, U. Testa, C. Chelucci, G. Macioce, I. Casella, P. Samoggia, C. Peschle, and H. J. Hassan
Stromal cell-derived factor 1{alpha} increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells
Blood, May 1, 2001; 97(9): 2587 - 2595.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. L. Colamussi, P. Secchiero, A. Gonelli, M. Marchisio, G. Zauli, and S. Capitani
Stromal derived factor-1{alpha} (SDF-1{alpha}) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway
J. Leukoc. Biol., February 1, 2001; 69(2): 263 - 270.
[Abstract] [Full Text]


Home page
Stem CellsHome page
M. Majka, J. Ratajczak, B. Lee, M. Honczarenko, R. Douglas, M. A. Kowalska, L. Silberstein, A. M. Gewirtz, and M. Z. Ratajczak
The Role of HIV-Related Chemokine Receptors and Chemokines in Human Erythropoiesis in Vitro
Stem Cells, March 1, 2000; 18(2): 128 - 138.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
Y. Sotsios, G. C. Whittaker, J. Westwick, and S. G. Ward
The CXC Chemokine Stromal Cell-Derived Factor Activates a Gi-Coupled Phosphoinositide 3-Kinase in T Lymphocytes
J. Immunol., December 1, 1999; 163(11): 5954 - 5963.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Ishii, M. Nishihara, F. Ma, Y. Ebihara, K. Tsuji, S. Asano, T. Nakahata, and T. Maekawa
Expression of Stromal Cell-Derived Factor-1/Pre-B Cell Growth-Stimulating Factor Receptor, CXC Chemokine Receptor 4, on CD34+ Human Bone Marrow Cells Is a Phenotypic Alteration for Committed Lymphoid Progenitors
J. Immunol., October 1, 1999; 163(7): 3612 - 3620.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Ochi, W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen, and J. A. Boyce
T Helper Cell Type 2 Cytokine–mediated Comitogenic Responses and CCR3 Expression During Differentiation of Human Mast Cells In Vitro
J. Exp. Med., July 19, 1999; 190(2): 267 - 280.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. Rabkin, Q.-e. Yang, J. J. Goedert, G. Nguyen, H. Mitsuya, and S. Sei
Chemokine and Chemokine Receptor Gene Variants and Risk of Non-Hodgkin's Lymphoma in Human Immunodeficiency Virus-1-Infected Individuals
Blood, March 15, 1999; 93(6): 1838 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Dürig, N. G. Testa, and C. M. Heyworth
Distinct Biological Effects of Macrophage Inflammatory Protein-1{alpha} and Stroma-Derived Factor-1{alpha} on CD34+ Hemopoietic Cells
Stem Cells, March 1, 1999; 17(2): 62 - 71.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. K. Ganju, S. A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin, W. Newman, and J. E. Groopman
The alpha -Chemokine, Stromal Cell-derived Factor-1alpha , Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways
J. Biol. Chem., September 4, 1998; 273(36): 23169 - 23175.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez, X.
Right arrow Articles by Navarro, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez, X.
Right arrow Articles by Navarro, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.